Quality key factors
Factor
Value
Sales Growth (5y)
0.00%
EBIT Growth (5y)
0.00%
EBIT to Interest (avg)
8.46
Debt to EBITDA (avg)
0.85
Net Debt to Equity (avg)
0.12
Sales to Capital Employed (avg)
0.73
Tax Ratio
33.07%
Dividend Payout Ratio
0
Pledged Shares
38.54%
Institutional Holding
36.96%
ROCE (avg)
14.20%
ROE (avg)
17.21%
Valuation Key Factors 
Factor
Value
P/E Ratio
92
Industry P/E
40
Price to Book Value
6.91
EV to EBIT
52.23
EV to EBITDA
43.68
EV to Capital Employed
6.29
EV to Sales
12.44
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
12.03%
ROE (Latest)
10.48%
Loading Valuation Snapshot...
3What is working for the Company
NET SALES(Q)
Highest at Rs 220.02 cr
PAT(Q)
Highest at Rs 48.54 cr.
EPS(Q)
Highest at Rs 7.55
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Symbiotec Pharma
Net Sales - Quarterly
Highest at Rs 220.02 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 48.54 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 7.55
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Here's what is not working for Symbiotec Pharma
Non Operating Income - Quarterly
Highest at Rs 20.23 cr
in the last five quartersMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating Income